D. Donald

发表

Recent Progress in Research on the Immunosuppressant FK-506

P. Kocieňski, Michael J. Stocks, D. Donald, 1990 .

Synthetic FKBP12 ligands. Design and synthesis of pyranose replacements.

S. Teague, M. Perry, Michael J. Stocks, 1994 .

SYNTHESIS AND EVALUATION OF DUAL DOMAIN MACROCYCLIC FKBP12 LIGANDS

S. Teague, Michael J. Stocks, D. Donald, 1994 .

Synthesis and study of a non macrocyclic FK506 derivative.

S. Teague, D. Donald, M. Cooper, 1994 .

The Specific Monocarboxylate Transporter-1 (MCT-1) Inhibitor, AR-C117977, Induces Donor-Specific Suppression, Reducing Acute and Chronic Allograft Rejection in the Rat

B. Veress, H. Ekberg, D. Donald, 2007, Transplantation.

The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.

N. C. Ray, K. J. Escott, R. Bull, 2013, Bioorganic & medicinal chemistry letters.

The discovery of new spirocyclic muscarinic M3 antagonists.

Daniel J. Warner, G. Pairaudeau, A. Bailey, 2010, Bioorganic & medicinal chemistry letters.

Potent blockers of the monocarboxylate transporter MCT1: novel immunomodulatory compounds.

A. Davis, D. Ferguson, L. Kingston, 2006, Bioorganic & medicinal chemistry letters.

The Specific Monocarboxylate Transporter (MCT1) Inhibitor, AR-C117977, a Novel Immunosuppressant, Prolongs Allograft Survival in the Mouse

I. Binet, K. Wood, D. Donald, 2007, Transplantation.

Optimization of monocarboxylate transporter 1 blockers through analysis and modulation of atropisomer interconversion properties.

T. Potter, R. Lewis, S. St-Gallay, 2007, Journal of medicinal chemistry.

C10 N-Acyl modified FK-506: A possible hybrid analogue of the transition state of peptidyl-prolyl cis-trans isomerization.

D. Donald, E. Wells, M. Cooper, 1991 .

A synthesis of the C16-C23 segment of FK-506

Michael J. Stocks, D. Donald, Philip Kocleński, 1990 .

Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H₁ antagonists. Part I.

B. Springthorpe, R. Riley, H. Beaton, 2012, Bioorganic & medicinal chemistry letters.

A Synthesis of the C24-C34 Segment of FK 506

M. Perry, P. Kocieňski, Michael J. Stocks, 1990 .

Fused mesoionic heterocycles: synthesis of [1,2,3]triazolo[1,5-a]quinoline, [1,2,3]triazolo[1,5-a]quinazoline, [1,2,3]triazolo[1,5-a]quinoxaline and [1,2,3]triazolo[5,1-c]benzotriazine derivatives

D. Donald, R. Bonnert, P. Cage, 2002 .

A synthesis of the C(1)-C(15) segment of tsukubaenolide (FK 506).

P. Kocieňski, Michael J. Stocks, D. Donald, 1988 .

Monocarboxylate transporter MCT1 is a target for immunosuppression

A. Ross, Leslie R Evans, A. Jackson, 2005, Nature chemical biology.

Studies relating to the immunosuppressive activity of FK506

D. Donald, M. Furber, Cooper Martin, 1993 .

Toward the Understanding of Immunosuppression

H. Kessler, D. Mierke, D. Donald, 1991 .

Studies Relating to the Immunosuppressive Activity of FK506 (I).

D. Donald, M. Furber, Cooper Martin, 1993 .

A simple and efficient synthesis of optically pure 4-alkylisoxazolidin-4-ols

D. Donald, S. Guile, M. Cooper, 2006 .

Immunosuppressive properties of a series of novel inhibitors of the monocarboxylate transporter MCT‐1

H. Ekberg, D. Donald, Z. Qi, 2013, Transplant international : official journal of the European Society for Organ Transplantation.

The discovery of AZD9164, a novel muscarinic M3 antagonist.

Keith Bowers, Ken Grime, Helen Edwards, 2011, Bioorganic & medicinal chemistry letters.

Novel P2X7 receptor antagonists.

M. Braddock, A. Baxter, M. Robertson, 2003, Bioorganic & medicinal chemistry letters.

Discovery of potent and selective adamantane-based small-molecule P2X(7) receptor antagonists/interleukin-1beta inhibitors.

Martin Braddock, Mark Furber, Keith Bowers, 2007, Journal of medicinal chemistry.